On Friday, Mizuho updated its stance on Herbalife (NYSE:HLF), increasing the stock's price target to $11.00 from the previous $10.00 while maintaining a Neutral rating. The firm's analyst cited improved execution and various positive trends as the basis for the adjustment.
Herbalife has been facing challenges for the past two and a half years, but recent developments indicate that the period of significant sales decline might be over. Noteworthy improvements have been observed, including growth among North American distributors due to new initiatives, stabilization in the Nielsen weight management segment, a return to growth in the Chinese market, and enhanced international productivity.
The company's trajectory appears to be positive, bolstered by cost-saving measures that have strengthened the EBITDA floor. Despite these encouraging signs, the analyst emphasized the need for additional time to confirm a definitive positive turn due to the ongoing volatile market conditions.
Mizuho has revised its EBITDA estimates upward, with forecasts for fiscal year 2024 now at $578 million, up from $566 million, and for fiscal year 2025 at $650 million, an increase from the previous $612 million projection. The new price target of $11 reflects a 5.5x multiple of the firm's calendar year 2024 EBITDA estimate.
The report acknowledges that while there is more confidence in Herbalife's EBITDA prospects, sales continue to be highly uncertain. However, the emergence of material supports for the company's business model has contributed to the improved financial outlook.
In other recent news, Herbalife Ltd. has reported a 1% year-over-year increase in net sales, reaching $1.3 billion for Q1 2024. The company's adjusted EBITDA also surpassed expectations, reaching $138 million with a 10.9% margin. The nutrition company has made significant strides in restructuring, including a $1.6 billion senior secured refinancing and a decrease in leverage ratio from 3.9x to 3.6x in Q1. Herbalife has also launched the Herbalife One project in the UK and Spain, simplifying transactions for distributors, and successfully trained 140,000 distributors through its Premier League program.
Looking ahead, Herbalife projects flat to a 3% increase in net sales for Q2, with adjusted EBITDA between $140 million and $160 million. The company anticipates net interest expenses to be $50 million to $60 million higher in 2024 compared to 2023, and plans to repay $262 million in bonds due in 2025 from business-generated cash flow.
Despite these challenges, Herbalife's restructuring is expected to deliver $40 million in savings in 2024 and at least $80 million annually starting in 2025. The company is also enhancing its competitive edge in the weight loss, wellness, and beauty markets with the launch of new digital tools and products.
InvestingPro Insights
Following Mizuho's updated outlook on Herbalife (NYSE:HLF), real-time data from InvestingPro highlights several key metrics that could be of interest to investors. With a market cap of $1.14 billion and an attractive P/E ratio of 8.23, which further improves to 7.12 when adjusted for the last twelve months as of Q1 2024, Herbalife demonstrates a compelling valuation. The company's significant return over the last week, month, and three months, at 10.97%, 13.62%, and 32.6% respectively, suggests a strong short-term performance.
InvestingPro Tips also provide additional insights, noting that Herbalife's valuation implies a strong free cash flow yield and that the company trades at a low earnings multiple. Furthermore, Herbalife's liquid assets are reported to exceed its short-term obligations, indicating financial resilience. For investors looking to delve deeper into Herbalife's financial health and future performance, there are additional InvestingPro Tips available. Use coupon code PRONEWS24 to get an extra 10% off a yearly or biyearly Pro and Pro+ subscription, unlocking a wealth of in-depth analysis and data.
It's also worth noting that while Herbalife does not pay a dividend, analysts predict the company will be profitable this year, as it has been over the last twelve months. These factors, combined with the recent positive trends identified by Mizuho, suggest a potentially favorable outlook for Herbalife's stock.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.